Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Nature (4)
Leukemia (2)
npj Vaccines (1)
Nature Immunology (1)
Nature Medicine (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (7)
Comments & Opinion (1)
News (1)

Subject Check one or more subjects to show results from those subjects only.

Cancer
Diseases
Health care
Immunology
Microbiology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–9 of 9 results

Advanced filters: Author: Thomas J. Waldschmidt Clear advanced filters

Plasmapheresis facilitates soluble BCMA clearance and contributes to reversing primary resistance to anti-BCMA immunotherapy in multiple myeloma

Sven Neubert
Umair Munawar
Johannes M. Waldschmidt
ResearchOpen Access10 Sept 2025
Leukemia

Volume: 39, P: 2563-2567
CpG motifs in bacterial DNA trigger direct B-cell activation

Arthur M. Krieg
Ae-Kyung Yi
Dennis M. Klinman
Research06 Apr 1995
Nature

Volume: 374, P: 546-549
Acquired CD40-ligand deficiency in chronic lymphocytic leukemia

Mark Cantwell
Tinh Hua
Thomas J. Kipps
Research01 Sept 1997
Nature Medicine

Volume: 3, P: 984-989
NASH limits anti-tumour surveillance in immunotherapy-treated HCC

In hepatocellular carcinoma driven by non-alcoholic steatohepatitis, aberrant T cell activation and impaired immune surveillance seem to make hepatocellular carcinoma less responsive to anti-PD1 or anti-PDL1 immunotherapy.

Dominik Pfister
Nicolás Gonzalo Núñez
Mathias Heikenwalder
ResearchOpen Access24 Mar 2021
Nature

Volume: 592, P: 450-456
Prof. R. Willstätter, For. Mem. R. S

THOMAS J. NOLAN
Comments & Opinion10 Oct 1942
Nature

Volume: 150, P: 424-425
Cosmic Rays and the Origin of Species

H. Hamshaw Thomas
News11 Jan 1936
Nature

Volume: 137, P: 51-53
Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection

Chronically infected mice upregulate expression of inhibitory molecules on exhausted T cells. Harty and colleagues report similar findings in human patients with malaria and show that blockade of the inhibitory receptors PD-L1 and LAG-3 restores antimalaria responses in mice.

Noah S Butler
Jacqueline Moebius
John T Harty
Research11 Dec 2011
Nature Immunology

Volume: 13, P: 188-195
Effect of bcr-abl oligodeoxynucleotides on the clonogenic growth of chronic myelogenous leukaemia cells

P de Fabritiis
T Skorski
B Calabretta
Research01 Jun 1997
Leukemia

Volume: 11, P: 811-819
Polyanhydride nanovaccine against H3N2 influenza A virus generates mucosal resident and systemic immunity promoting protection

Christopher E. Lopez
Zeb R. Zacharias
Kevin L. Legge
ResearchOpen Access31 May 2024
npj Vaccines

Volume: 9, P: 1-14